News from Zyme and the companies we work with.
Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases
Clinical stage company formed from the merger of Oxitope Pharma and Arxx Therapeutics Calluna Pharma has a pipeline of selective antibodies targeting immunological diseases New company to complete multiple clinical [...]
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness Dublin, Ireland, and Tampere, Finland, 17 January 2024: ERS Genomics Limited [...]
Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders
Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic and technical perspectives Cambridge, UK, [...]
Metrion Biosciences closes £3.7m new equity financing
Financing led by Maven Capital Partners, alongside Gresham House Ventures Funds to be used to expand Metrion’s Cambridge UK laboratories and to enhance scientific and commercial capabilities Dr David Milroy [...]
Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office
Patent JP6692856 upheld for second time in response to invalidation challenge Dublin, Ireland, 13 December 2023: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 [...]
Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing
Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions Cambridge, UK, 13 December, 2023: Sphere Fluidics, a leading provider of innovative microfluidics-based [...]
SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel
Phase IIa clinical trial evaluated Aurase Wound Gel in patients with venous leg ulcers Former Smith+Nephew CMO, Andy Weymann joins as Chairman to support progression of further Phase II clinical [...]
DeepMirror launches early access programme for its intuitive molecular drug design software
Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery Cambridge, UK, 11 December 2023: DeepMirror, a University of Cambridge [...]
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
Biotage® PeptiPEC high-throughput kits facilitate fast and low solvent consumption solution for plate-based peptide purification Partnership complements Gyros’ PurePep® EasyClean technology offering with an automated solution for advanced discovery process [...]
Optibrium’s Quantum Mechanics and Machine Learning Methods Predict Routes of Drug Metabolism
Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity and greater precision than other [...]
Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board
Supports ambitious commercialisation strategy for DNA synthesis platform, gSynth Follows $10m Series A financing to scale operations Cambridge, UK, 06 December 2023: Camena Bioscience, a synthetic biology company providing genes [...]
Evonetix Announces Agreement for Revolutionary Gene Synthesis Platform with Analog Devices
The companies are working together on next-generation technology in the fast-growing field of synthetic biology. This new technology will improve the quality, speed, and cost of developing synthetic biological solutions [...]